http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2645090-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a6289b957369e15597b9b73392417e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_639bbcc9d9541b49ed0a0741ef0246f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b37e204d4370b82e40b22621a6ddf1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_771f824f9c5d62d6e0dd62969c73f5c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e157f92c7b9906b7a3cffb81095bb0
publicationDate 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2645090-C1
titleOfInvention Method for prevention and treatment of polar desynchronosis
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, specifically, to therapy and chronobiology, and concerns the prevention and treatment of polar desynchronosis. To this end, the subject is placed in a three-dimensional isolated space with a stable internal chronostructure, independent of the external environment, for a period of not less than 3 days. Drug metaproth is additionally administered. Administration is carried out simultaneously at a dose of 0.75, or at an average therapeutic dose until the symptoms of desynchronosis disappear. n EFFECT: this ensures efficient and rapid re-synchronisation of the body due to the anti-asthenic and immunomodulatory action of metaproth. n 1 cl, 1 tbl
priorityDate 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0054837-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426122397
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID93760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID93760

Total number of triples: 32.